Aslam Rabbiya, Herrles Laura, Aoun Raquel, Pioskowik Anna, Pietrzyk Agata
Scientific Group of Microbiology and Parasitology and the Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.
J Allergy Clin Immunol Glob. 2024 Jun 12;3(3):100289. doi: 10.1016/j.jacig.2024.100289. eCollection 2024 Aug.
Asthma, a chronic inflammatory disorder of the airways, is a prevalent childhood chronic disease with a substantial global health burden. The complex etiology and pathogenesis of asthma involve genetic and environmental factors, posing challenges in diagnosis, severity prediction, and therapeutic strategies. Recent studies have highlighted the significant role of the gut microbiota and its interaction with the immune system in the development of asthma. Dysbiosis, an imbalance in microbial composition, has been associated with respiratory diseases through the gut-lung axis. This axis is an interaction between the gut and lungs, allowing microbial metabolites to influence the host immune system. This systematic review examines the association between gut microbiota composition, measured using 16S rRNA sequencing, during infancy and childhood, and the subsequent development of atopic wheeze and asthma. The results suggest that higher alpha diversity of bacteria such as , and may have protective effects against asthmatic outcomes. Conversely, lower relative abundances of bacteria like and certain fungi, including , were associated with asthma. These findings highlight the potential of early screening and risk assessment of gut microbiota to identify individuals at risk of asthma. Furthermore, investigations targeting gut microbiota, such as dietary modifications and probiotic supplementation, may hold promise for asthma prevention and management. Future research should focus on identifying specific microbial signatures associated with asthma susceptibility and further investigate approaches like fecal microbiota transplantation. Understanding the role of gut microbiota in asthma pathogenesis can contribute to early detection and development of interventions to mitigate the risk of asthmatic pathogenesis in childhood.
哮喘是一种气道慢性炎症性疾病,是一种常见的儿童慢性病,给全球健康带来沉重负担。哮喘复杂的病因和发病机制涉及遗传和环境因素,在诊断、严重程度预测和治疗策略方面带来了挑战。最近的研究强调了肠道微生物群及其与免疫系统的相互作用在哮喘发展中的重要作用。生态失调,即微生物组成的失衡,已通过肠-肺轴与呼吸系统疾病相关联。这个轴是肠道和肺部之间的一种相互作用,使微生物代谢产物能够影响宿主免疫系统。本系统综述研究了在婴儿期和儿童期使用16S rRNA测序测量的肠道微生物群组成与随后特应性喘息和哮喘发展之间的关联。结果表明,较高的α多样性,如某些细菌,可能对哮喘结局具有保护作用。相反,较低的相对丰度,如某些细菌和某些真菌,包括某些种类,与哮喘有关。这些发现突出了对肠道微生物群进行早期筛查和风险评估以识别哮喘高危个体的潜力。此外,针对肠道微生物群的研究,如饮食调整和补充益生菌,可能对哮喘的预防和管理具有前景。未来的研究应侧重于确定与哮喘易感性相关的特定微生物特征,并进一步研究如粪便微生物群移植等方法。了解肠道微生物群在哮喘发病机制中的作用有助于早期发现并开发干预措施,以降低儿童哮喘发病机制的风险。